These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2525529)

  • 41. Teicoplanin: a new glycopeptide antibiotic complex.
    Babul N; Pasko M
    Drug Intell Clin Pharm; 1988 Mar; 22(3):218-26. PubMed ID: 2966729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Teicoplanin in open fractures: a preliminary report.
    Hughes SP; Strachan E; Miles R; Williams AH
    Eur J Surg Suppl; 1992; (567):15-7. PubMed ID: 1381635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Teicoplanin as modification of initial empirical therapy in febrile granulocytopenic patients.
    Nováková IR; Donnelly JP; Verhagen CS; De Pauw BE
    J Antimicrob Chemother; 1990 Jun; 25(6):985-93. PubMed ID: 2142486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA; Whitehouse T; Cooper B; Hails J; Jones K; Kwaku F; Taylor L; Hayman S; Shaw S; Kibbler C; Shulman R; Singer M; Wilson AP
    J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Teicoplanin versus flucloxacillin in the treatment of infection following burns.
    Steer JA; Papini RP; Wilson AP; McGrouther DA; Parkhouse N
    J Antimicrob Chemother; 1997 Mar; 39(3):383-92. PubMed ID: 9096188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of teicoplanin for enterococcal infections: 63 cases and review.
    Schmit JL
    Clin Infect Dis; 1992 Aug; 15(2):302-6. PubMed ID: 1387808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotic prophylaxis in cardiac surgery: serum and tissue levels of teicoplanin, flucloxacillin and tobramycin.
    Wilson AP; Taylor B; Treasure T; Grüneberg RN; Patton K; Felmingham D; Sturridge MF
    J Antimicrob Chemother; 1988 Feb; 21(2):201-12. PubMed ID: 2966139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of teicoplanin as antimicrobial treatment of severe nosocomial infections caused by gram-positive bacteria: a preliminary study.
    Micozzi A; Venditti M; Brandimarte C; Baiocchi P; Martino P; Serra P
    Chemioterapia; 1988 Apr; 7(2):101-4. PubMed ID: 2969302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized comparison trial of teicoplanin i.v., teicoplanin i.m., and cefazolin therapy for skin and soft tissue infections caused by gram-positive bacteria.
    Chirurgi VA; Edelstein H; Oster SE; Karp R; Cassano KB; Aiken S; McCabe RE
    South Med J; 1994 Sep; 87(9):875-80. PubMed ID: 8091249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of gram-positive therapy in the neutropenic patient.
    Menichetti F; Del Favero A
    J Antimicrob Chemother; 1991 Apr; 27 Suppl B():51-60. PubMed ID: 1829077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Teicoplanin therapy in children: a review.
    Bassetti D; Cruciani M
    Scand J Infect Dis Suppl; 1990; 72():35-7. PubMed ID: 2151065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of gram-positive and Candida albicans infections using teicoplanin and fluconazole: a randomized study in neutropenic children.
    Schaison G; Baruchel A; Arlet G
    Br J Haematol; 1990 Dec; 76 Suppl 2():24-6. PubMed ID: 2149047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Teicoplanin pharmacokinetics in healthy volunteers after administration of intravenous loading and maintenance doses.
    Outman WR; Nightingale CH; Sweeney KR; Quintiliani R
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2114-7. PubMed ID: 2149920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Teichoplanin: a clinical study of treatment of serious infections in hospitalized patients].
    Di Rosa R; Maira S; Guido F; Cossu MF; Amoroso A
    Riv Eur Sci Med Farmacol; 1995; 17(6):231-5. PubMed ID: 8766478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients.
    Cony-Makhoul P; Brossard G; Marit G; Pellegrin JL; Texier-Maugein J; Reiffers J
    Br J Haematol; 1990 Dec; 76 Suppl 2():35-40. PubMed ID: 2149050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections.
    Wilcox M; Nathwani D; Dryden M
    J Antimicrob Chemother; 2004 Feb; 53(2):335-44. PubMed ID: 14729745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of teicoplanin in the elderly.
    Rosina R; Villa G; Danese A; Cavenaghi L; Picardi L; Salvadeo A
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():39-45. PubMed ID: 2965130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Teicoplanin--domiciliary use in surgical infections.
    Rubinstein E
    Eur J Surg Suppl; 1992; (567):27-9. PubMed ID: 1381638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of teicoplanin in children.
    Tarral E; Jehl F; Tarral A; Simeoni U; Monteil H; Willard D; Geisert J
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():47-51. PubMed ID: 2965131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Concentrations of teicoplanin in serum and atrial appendages of patients undergoing cardiac surgery.
    Bergeron MG; Saginur R; Desaulniers D; Trottier S; Goldstein W; Foucault P; Lessard C
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1699-702. PubMed ID: 2149493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.